---

On To the Point, Jeremy Sharp and Kahaari Kenyatta of Waxman Strategies discuss the upcoming FDA user fee reauthorization process.
       

Source: The Commonwealth Fund: Blog - July 23, 2020 Category: International Medicine & Public Health Authors: Jeremy Sharp, Kahaari Kenyatta Source Type: blogs